REGENERON PHARMACEUTICALS, INC. Interest Expense 2008-2024 | REGN
What is interest expense?
Interest expense represents the cost of borrowing money, including interest paid on bonds, loans, and other debt obligations.
What is REGENERON PHARMACEUTICALS, INC.'s current interest expense?
REGENERON PHARMACEUTICALS, INC. (REGN) annual interest expense for 2023 was $73.0M, a 22.90% increase from 2022. REGENERON PHARMACEUTICALS, INC. interest expense for the quarter ending March 31, 2024 was $16.1M.
What was REGENERON PHARMACEUTICALS, INC.'s interest expense in 2022?
REGENERON PHARMACEUTICALS, INC. annual interest expense for 2022 was $59.4M, a 3.66% increase from 2021.
What was REGENERON PHARMACEUTICALS, INC.'s interest expense in 2021?
REGENERON PHARMACEUTICALS, INC. annual interest expense for 2021 was $57.3M, a 0.70% increase from 2020.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year interest expense CAGR?
REGENERON PHARMACEUTICALS, INC. interest expense grew at a compound annual growth rate (CAGR) of 20.95% from FY2018 to FY2023, going from $28.2M to $73.0M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2023 | $73.0M | +22.9% | 10-K |
| FY2022 | $59.4M | +3.7% | 10-K |
| FY2021 | $57.3M | +0.7% | 10-K |
| FY2020 | $56.9M | +88.4% | 10-K |
| FY2019 | $30.2M | +7.1% | 10-K |
| FY2018 | $28.2M | +12.4% | 10-K |
| FY2017 | $25.1M | +248.6% | 10-K |
| FY2016 | $7.2M | -49.4% | 10-K |
| FY2015 | $14.2M | -61.9% | 10-K |
| FY2014 | $37.4M | -19.5% | 10-K |
| FY2013 | $46.4M | +2.5% | 10-K |
| FY2012 | $45.3M | +112.9% | 10-K |
| FY2011 | $21.3M | +133.4% | 10-K |
| FY2010 | $9.1M | +290.2% | 10-K |
| FY2009 | $2.3M | -69.9% | 10-K |
| FY2008 | $7.8M | - | 10-K |